BIOMARKER ANALYSIS SERVICES
Mercodia offers a wide range of bioanalytical testing solutions, including large molecules, biomarkers, biosimilars, peptides, and oligonucleotides. Our services are tailored to support pharmaceutical and biotechnology companies at every stage of drug development. Understanding the specific context of use of a biomarker is essential for designing a cost- and time-effective bioanalytical strategy.
Receive your quote directly from the manufacturer.
BIOMARKER ANALYSIS SERVICES
Biomarker-driven drug development is widely used and has the potential to make drug discovery, development, and approval processes more efficient while improving patient outcomes. The data derived from biomarkers plays a key role in decision-making throughout the entire drug development pipeline, from drug mode of action, efficacy, and safety assessments to patient stratification and evaluation of clinical trial endpoints.
Mercodia understand that the specific context of biomarker use is crucial for designing a bioanalytical strategy that is both cost-effective and time efficient. Our experts provide valuable insights to help you tailor your strategy to precisely fit the needs of your study.
Mercodia offer an extensive portfolio featuring 500+ biomarkers and panels. We are continuously expanding our offerings to enable healthcare providers, researchers, and clinicians to address a broad spectrum of clinical and research questions.
Can't find the specific biomarker you're looking for? No problem! Contact us, and our dedicated team will work with you to provide a customized solution that aligns with your unique requirements.
